F Javier Carmona Sanz

Cited by

	All	Since 2019
Citations	4211	2055
h-index	27	23
i10-index	31	28

480

240

120

360

20102011201220132014201520162017201820192020202120222023202412 32 88 157 236 345 361 452 419 462 405 447 363 291 87

Public access

View all

24 articles

0 articles

available

not available

Based on funding mandates

Co-authors

Holger HeynCNAG-CRGVerified email at cnag.crg.eu
sergi sayolsInstitute of Molecular Biology MainzVerified email at imb-mainz.de
Agustin F Fernandez (ORCID: 0000-0...Tenured Scientist CSIC https://ror.org/02gfc7t72; Universidad de Oviedo https://ror.org/006gksa02Verified email at cinn.es
Jose V. Sanchez-MutNeuroscience Institute of Alicante, CSIC-UMHVerified email at umh.es
Ivo GutDirector, Centro Nacional de Analisis Genomico, CNAG-CRG, Center for Genomic RegulationVerified email at cnag.crg.eu
Gertrud LundCinvestavVerified email at ira.cinvestav.mx
Simon HeathSenior Team Leader, CNAG, Center Nacional de Análisis GenómicoVerified email at cnag.crg.es
Alfonso ValenciaICREA Professor. Barcelona Supercomputing Center.Verified email at bsc.es
Jorunn E EyfjordFaculty of Medicine, University of IcelandVerified email at hi.is
Olafur StefanssonUniversity of IcelandVerified email at hi.is
Jordana T BellKing's College LondonVerified email at kcl.ac.uk
Andrea Sartore-BianchiClinical Molecular Oncology, Niguarda Cancer Center, Milano - ItalyVerified email at ospedaleniguarda.it
Andrea CassingenaATS Milano Città MetropolitanaVerified email at ats-milano.it
Salvatore SienaUniversità degli Studi di Milano, Dipartimento di Oncologia, Ospedale Niguarda, Milano, ItalyVerified email at unimi.it
Tim D SpectorGuys and St Thomas Hospital NHS Trust, Kings College LondonVerified email at kcl.ac.uk
Alejandro Sanchez-FloresHead of Sequencing and Bioinformatics University core laboratory, National Autonomous University ofVerified email at ibt.unam.mx
Joaquin DopazoComputational Medicine Platform, FPS, Hospital Virgen del Rocio, Sevilla, SpainVerified email at juntadeandalucia.es
Modesto OrozcoProfessor of Biochemistry, Universtity of BarcelonaVerified email at irbbarcelona.org
Chiara AmbrogioAssociate Professor, University of TurinVerified email at unito.it
Mariano BarbacidCNIOVerified email at cnio.es

F Javier Carmona Sanz

Vall d'Hebron Institute of Oncology

Verified email at vhio.net


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Distinct DNA methylomes of newborns and centenarians H Heyn, N Li, HJ Ferreira, S Moran, DG Pisano, A Gomez, J Diez, ... Proceedings of the National Academy of Sciences 109 (26), 10522-10527, 2012	880	2012
A prognostic DNA methylation signature for stage I non–small-cell lung cancer J Sandoval, J Mendez-Gonzalez, E Nadal, G Chen, FJ Carmona, ... Journal of clinical oncology 31 (32), 4140-4147, 2013	311	2013
The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer AF Fernandez, C Rosales, P Lopez-Nieva, O Graña, E Ballestar, ... Genome research 19 (3), 438-451, 2009	300	2009
DNA methylation map of human atherosclerosis S Zaina, H Heyn, FJ Carmona, N Varol, S Sayols, E Condom, ... Circulation: Cardiovascular Genetics 7 (5), 692-700, 2014	255	2014
Quantitative comparison of DNA methylation assays for biomarker development and clinical applications Nature biotechnology 34 (7), 726-737, 2016	237	2016
PDK1-SGK1 signaling sustains AKT-independent mTORC1 activation and confers resistance to PI3Kα inhibition P Castel, H Ellis, R Bago, E Toska, P Razavi, FJ Carmona, S Kannan, ... Cancer cell 30 (2), 229-242, 2016	220	2016
DNA methylation profiling in breast cancer discordant identical twins identifies DOK7 as novel epigenetic biomarker H Heyn, FJ Carmona, A Gomez, HJ Ferreira, JT Bell, S Sayols, K Ward, ... Carcinogenesis 34 (1), 102-108, 2013	192	2013
Somatic PIK3CA mutations as a driver of sporadic venous malformations P Castel, FJ Carmona, J Grego-Bessa, MF Berger, A Viale, KV Anderson, ... Science translational medicine 8 (332), 332ra42-332ra42, 2016	168	2016
DNA methylation biomarkers for noninvasive diagnosis of colorectal cancer FJ Carmona, D Azuara, A Berenguer-Llergo, AF Fernández, S Biondo, ... Cancer prevention research 6 (7), 656-665, 2013	139	2013
Aberrant DNA methylation in non-small cell lung cancer-associated fibroblasts M Vizoso, M Puig, FJ Carmona, M Maqueda, A Velásquez, A Gómez, ... Carcinogenesis 36 (12), 1453-1463, 2015	125	2015
Epigenetic activation of a cryptic TBC1D16 transcript enhances melanoma progression by targeting EGFR M Vizoso, HJ Ferreira, P Lopez-Serra, FJ Carmona, A Martínez-Cardús, ... Nature medicine 21 (7), 741-750, 2015	119	2015
Silencing of Kruppel-like factor 2 by the histone methyltransferase EZH2 in human cancer H Taniguchi, FV Jacinto, A Villanueva, AF Fernandez, H Yamamoto, ... Oncogene 31 (15), 1988-1994, 2012	118	2012
The DNA methylation drift of the atherosclerotic aorta increases with lesion progression MP Valencia-Morales, S Zaina, H Heyn, FJ Carmona, N Varol, S Sayols, ... BMC medical genomics 8, 1-9, 2015	117	2015
Epigenetic inactivation of the BRCA1 interactor SRBC and resistance to oxaliplatin in colorectal cancer C Moutinho, A Martinez-Cardús, C Santos, V Navarro-Pérez, ... Journal of the national cancer institute 106 (1), djt322, 2014	108	2014
Impaired DICER1 function promotes stemness and metastasis in colon cancer MS Iliou, V da Silva-Diz, FJ Carmona, J Ramalho-Carvalho, H Heyn, ... Oncogene 33 (30), 4003-4015, 2014	102	2014
Epigenetic disruption of cadherin‐11 in human cancer metastasis FJ Carmona, A Villanueva, A Vidal, C Munoz, S Puertas, RM Penin, ... The Journal of pathology 228 (2), 230-240, 2012	86	2012
A comprehensive DNA methylation profile of epithelial-to-mesenchymal transition FJ Carmona, V Davalos, E Vidal, A Gomez, H Heyn, Y Hashimoto, ... Cancer research 74 (19), 5608-5619, 2014	79	2014
Comprehensive DNA methylation study identifies novel progression-related and prognostic markers for cutaneous melanoma J Wouters, M Vizoso, A Martinez-Cardus, FJ Carmona, O Govaere, ... BMC medicine 15, 1-16, 2017	77	2017
Epigenomics of human colon cancer FJ Carmona, M Esteller Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 693 (1 …, 2010	77	2010
Neratinib is effective in breast tumors bearing both amplification and mutation of ERBB2 (HER2) E Cocco, F Javier Carmona, P Razavi, HH Won, Y Cai, V Rossi, C Chan, ... Science signaling 11 (551), eaat9773, 2018	69	2018

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors